PRRT2 and neurodegenerative disease: Relevant literature has reported on TREM2 and PLCγ2, as well as the potential role of protein kinase C (PKC) and PKC regulators as new therapies for neuroinflammation and neurodegenerative diseases in promoting the activation of repair/regeneration microglia subtypes (8).